Understanding Sepsis-Induced Cardiomyopathy
Author Information
Author(s): Muacevic Alexander, Adler John R, Borkowski Pawel, Borkowski Michal, Borkowska Natalia, Modak Vishakha, Nazarenko Natalia, Mangeshkar Shaunak, Osabutey Anita, Maliha Maisha, Chowdhury Ishmum, Batikyan Ashot, Adal Bisrat, Satish Vikyath
Primary Institution: Albert Einstein College of Medicine, Jacobi Medical Center, New York, USA
Hypothesis
What are the inflammatory pathways and potential therapeutic targets for sepsis-induced cardiomyopathy?
Conclusion
Sepsis-induced cardiomyopathy is a reversible condition that can significantly improve with supportive care, but it lacks standardized diagnostic criteria.
Supporting Evidence
- The patient showed significant recovery of left ventricular function after supportive care.
- SICM is associated with high mortality rates in septic shock.
- Current biomarkers lack specificity for diagnosing SICM.
- Inflammatory mediators play a central role in the development of SICM.
- Targeted therapies may help manage SICM effectively.
Takeaway
Sepsis can hurt the heart, but with the right care, the heart can get better. Doctors are trying to find better ways to spot and treat this problem.
Limitations
The study highlights the lack of a unified definition and standardized diagnostic criteria for sepsis-induced cardiomyopathy.
Participant Demographics
The case study involves a 69-year-old woman with a history of hypertension, hyperlipidemia, and type 2 diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website